Understanding how a protein in liver cells affects cholesterol production.
The role of hepatocyte tPA in hepatic VLDL production.
This study is looking at how a protein called tPA affects liver cells and their ability to produce cholesterol-carrying particles, which could help find new ways to lower bad cholesterol and reduce the risk of heart disease for people who are at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-11045744 on NIH RePORTER |
What this research studies
This research investigates the role of tissue-type plasminogen activator (tPA) in liver cells and its impact on the production of cholesterol-carrying particles known as very-low-density lipoproteins (VLDL). By studying the mechanisms through which tPA influences the levels of these lipoproteins, the research aims to uncover new insights into managing cholesterol levels and reducing cardiovascular disease risk. The approach involves both laboratory experiments with liver cells and animal models to explore how tPA can potentially lower harmful cholesterol levels in the blood. This could lead to new therapeutic strategies for patients at risk of atherosclerosis and related cardiovascular conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with elevated cholesterol levels or those at high risk for atherosclerosis and cardiovascular diseases.
Not a fit: Patients with normal cholesterol levels or those not at risk for cardiovascular diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that more effectively lower cholesterol levels and reduce the risk of cardiovascular diseases.
How similar studies have performed: Previous research has shown promising results in understanding the role of tPA in cholesterol metabolism, suggesting that this approach could yield significant insights.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Zheng, Ze — Medical College of Wisconsin
- Study coordinator: Zheng, Ze
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.